Scientific Origin and Academic Research Foundation
GreenWay Herbal Products, LLC was founded on the principle of following rigorous scientific research to identify novel bioactive compounds with therapeutic relevance.
In 2016, the founders partnered with the world-renowned Middle Tennessee State University (MTSU) to support research initiatives focused on botanical medicine, pharmacology, and translational science.
Research & Partnership
Tennessee Center for Botanical Medicine Research
Tennessee Center for Botanical Medicine Research
The Tennessee Center for Botanical Medicine Research (TCBMR) at MTSU was established in 2011 to advance the discovery and characterization of biologically active plant-derived compounds with potential pharmaceutical applications.
TCBMR is an interdisciplinary research center comprising faculty expertise across biology and chemistry, including rapid in vitro cellular screening, compound isolation and purification, and pharmacological evaluation of antibacterial, anticancer, antifungal, antiviral, antiparasitic, and immunomodulatory agents.
Global Botanical Research & Discovery
TCBMR employs a bioassay-guided research approach and maintains an exclusive research and licensing agreement with the Guangxi Botanical Garden of Medicinal Plants (GBGMP) in Nanning, China, the world’s largest medicinal plant repository.
This collaboration enables access to plant species with documented use in traditional medicine that have not yet been systematically evaluated in Western pharmaceutical research frameworks.
Research Outcomes and Intellectual Property
To date, TCBMR research efforts have identified multiple bioactive compounds relevant to oncology, infectious disease, and immune modulation. These discoveries have supported patent filings and ongoing intellectual property development.
GreenWay Herbal Products, LLC holds intellectual property arising from this academic research and focuses on advancing select cannabinoid-derived and botanical discoveries toward regulated pharmaceutical development, preclinical evaluation, and strategic licensing opportunities.